-
Vogt-koyanagi-harada syndrome.
PURPOSE: Vogt-Koyanagi-Harada syndrome is a bilateral, chronic, diffuse granulomatous ... The IL17/23 pathway may provide a novel therapeutic target to control ...
-
Vogt-Koyanagi-Harada Syndrome - Current Eye Research
Purpose: Vogt-Koyanagi-Harada syndrome is a bilateral, chronic, diffuse granulomatous panuveitis frequently associated with neurological, auditory, an...
-
Phenotypic and functional features of human Th17 cells ...
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights ... Cells Associated with Active Uveitis in Vogt-Koyanagi-Harada Syndrome. ...
-
(WO/2007/027761) USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT ...
[0041] Vogt-Koyanagi Harada (VKH): Vogt-Koyanagi-Harada syndrome (VKH) ... inflammatory bowel disease, juvenile rheumatoid arthritis, Reiter's syndrome, sarcoidosis, syphilis, ...
-
Use of IL-23 and IL-17 antagonists to treat autoimmune ocular ...
[0044]Vogt-Koyanagi Harada (VKH): Vogt-Koyanagi-Harada syndrome (VKH), formerly known as ... bowel disease, juvenile rheumatoid arthritis, Reiter's syndrome, sarcoidosis, ...
-
Molecular Vision: T-helper 17 lymphocytes in ocular ...
IL17, TGF-β, IL4, and IFN-γ levels were determined in plasma of OCP and healthy ... The stage of disease was defined according to the Foster-Mondino classification ...
-
Th17 or T(h)17, Primary Sclerosing Cholangitis Literature
... that IL-23 be considered as a possible master regulator of Crohn's disease. ... are increased in Crohn's disease and correlate with disease activity and IL-23R ...
-
IL-17, Primary Sclerosing Cholangitis Literature
Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: ... A. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. ...
-
T-helper 17 lymphocytes in ocular cicatricial pemphigoid (PDF)
IL17/CD4 antibodies and stained cells were then counted by confocal microscopy ... Fang W, Yang P. Vogt-koyanagi-harada syndrome. Curr Eye. Res 2008; 33: ...
-
Ophthal Medical News
Vogt-Koyanagi-Harada Syndrome ... multi-center studies are needed to determine the optimal treatment regime for this disease. The IL17/23 pathway may provide ...
